1132969-95-9

Basic information

• Product Name: (R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)-2-(trityloxy)ethanol
• Synonyms: (R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)-2-(trityloxy)ethanol
• CAS NO: 1132969-95-9
• Molecular Weight: 697.99
• Mol File: 1132969-95-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)-2-(trityloxy)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)-2-(trityloxy)ethanol(1132969-95-9)
• EPA Substance Registry System: (R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)-2-(trityloxy)ethanol(1132969-95-9)

Safety Data

• Hazardous Substances Data: 1132969-95-9(Hazardous Substances Data)

Upstream product

• 1239498-96-4 (2R,3S)-3-(tert-butyldiphenylsilyloxy)-2-methylbutanal 
• 1379802-66-0 (R)-4-benzyl-3-((2R,3S)-3-(tert-butyldiphenylsilyloxy)-2-methylbutanoyl)oxazolidin-2-one 
• 1379802-88-6 (2R,3S)-benzyl 3-(tert-butyldiphenylsilyloxy)-2-methylbutanoate 
• 1379802-67-1 (2S,3S)-3-(tert-butyldiphenylsilyloxy)-2-methylbutan-1-ol 
• 468756-88-9 (4R,2'R,3'S)-N-(3-hydroxy-2-methylbutanoyl)-4-benzyl-2-oxazolidinone 
• 76-83-5 trityl chloride 
• 3292-82-8 α-trityloxyacetaldehyde 
• 16975-62-5 tritylglycerol 
• 507-40-4 tert-butylhypochlorite 
• 1132969-93-7 (2S,3S)-3-(tert-butyldiphenylsilyloxy)-2-methylbutanal oxime 
• 1132969-94-8 (S,Z)-1-(trityloxy)pent-3-en-2-ol 

Downstream Products

• 1132970-05-8 (R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)ethane-1,2-diol 
• 1132969-96-0 (R)-4-((1R,2R,4R,5S)-5-(tert-butyldiphenylsilyloxy)-1-hydroxy-2,4-dimethyl-3-oxohexyl)-1,3-dioxolan-2-one 
• 1132970-08-1 (R)-4-((1R,2S,3R,4S,5S)-5-(tert-butyldiphenylsilyloxy)-1,3-dihydroxy-2,4-dimethylhexyl)-1,3-dioxolan-2-one 
• 1132970-07-0 C₂₇H₃₈O₆Si 
• 1132970-10-5 (R)-1-((4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)ethane-1,2-diol 
• 1132969-86-8 (4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxane-4-carbaldehyde 
• 1132969-84-6 methyl (2Z,4E,6R,7S,8S,10E,14S)-14-((4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)-14-hydroxy-2-methoxy-4,6,8,10-tetramethyl-7-(triethylsilyloxy)tetradeca-2,4,10-trien-12-ynoate 
• 1132970-12-7 (2Z,4E,6R,7S,8S,10E,12E,14S)-methyl 14-((4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)-7-hydroxy-2,14-dimethoxy-4,6,8,10-tetramethyltetradeca-2,4,10,12-tetraenoate 
• 1132970-13-8 (2Z,4E,6R,7S,8S,10E,12E,14S)-methyl 14-((4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)-7-(formyloxy)-2,14-dimethoxy-4,6,8,10-tetramethyltetradeca-2,4,10,12-tetraenoate 
• 1132969-98-2 methyl (2Z,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S,19S)-19-(tert-butyldiphenylsilyloxy)-7,15,17-trihydroxy-2,14-dimethoxy-4,6,8,10,16,18-hexamethylicosa-2,4,10,12-tetraenoate 
• 1132970-14-9 (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-((2S,3R,4S,5S)-5-(tert-butyldiphenylsilyloxy)-3-hydroxy-4-methylhexan-2-yl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one 
• 1379802-76-2 (2Z,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S,19S)-methyl 19-(tert-butyldiphenylsilyloxy)-7-(formyloxy)-15,17-dihydroxy-2,14-dimethoxy-4,6,8,10,16,18-hexamethylicosa-2,4,10,12-tetraenoate 

Relevant articles and documents

Total synthesis of bafilomycin A1

A convergent synthesis of bafilomycin A1, a potent inhibitor of V-type ATPases, is presented. The synthesis relies on the zinc triflate mediated diastereoselective addition of a complex enyne to a sensitive aldehyde as the key fragment coupling. A ruthenium-catalyzed trans-reduction of the resulting propargylic enyne efficiently installs the required C10-C13 trans,trans-diene subunit, implementing an alternative strategy to traditional palladium-catalyzed cross-coupling strategies. A highly selective oxidation of a secondary hydroxyl group in a triol sets the stage for the completion of the synthesis. Copyright